000 | 01150nam a22003137a 4500 | ||
---|---|---|---|
008 | 170823s20172017 xxu||||| |||| 00| 0 eng d | ||
022 | _a1878-0938 | ||
040 | _aOvid MEDLINE(R) | ||
099 | _a28577795 | ||
245 | _aFDA Town Hall at CRT 2017: Current status and future endeavors in cardiovascular devices. [Review] | ||
251 | _aCardiovascular Revascularization Medicine. 18(4):308-311, 2017 Jun | ||
252 | _aCardiovasc Revasc Med. 18(4):308-311, 2017 Jun | ||
253 | _aCardiovascular revascularization medicine : including molecular interventions | ||
260 | _c2017 | ||
260 | _fFY2017 | ||
266 | _d2017-08-23 | ||
501 | _aAvailable in print through MWHC library: 2002 - present | ||
546 | _aEnglish | ||
650 | _aIN PROCESS -- NOT YET INDEXED | ||
651 | _aMedStar Heart & Vascular Institute | ||
657 | _aJournal Article | ||
657 | _aReview | ||
700 | _aAlraies, M Chadi | ||
700 | _aBuchanan, Kyle | ||
700 | _aWaksman, Ron | ||
790 | _aAlraies MC, Buchanan KD, Waksman R | ||
856 |
_uhttps://dx.doi.org/10.1016/j.carrev.2017.04.015 _zhttps://dx.doi.org/10.1016/j.carrev.2017.04.015 |
||
942 |
_cART _dArticle |
||
999 |
_c2609 _d2609 |